Life Sciences

San Diego Life Sciences

Get in touch with our Life Sciences experts

CBRE’s San Diego Life Sciences Practice Group is a specialized team of market experts offering industry-leading commercial real estate services to tenants, landlords, buyers and sellers. Our extensive experience, global platform and resources, and deep understanding of the life sciences industry and it’s unique requirements, allow us to meet our clients' objectives and execute successful real estate strategies that drive results.

The most robust end-to-end services in the industry

Life Sciences Occupier Services

Real estate to create better outcomes for your life sciences business.

Learn More

Occupier Services

CBRE provides solutions supporting facilities, labs, manufacturing space and critical environments for a broad range of companies including pharmaceuticals, contract research organizations (CROs), biotech firms, contract manufacturing organizations (CMOs), medical device companies and the genomics industry. 

Life Sciences Investor Services

Real estate solutions down to a science

Learn More

Investor Services

Our team covers the full cycle of investment. With focused experience, proven practices and real-time data, we provide integrated solutions for all life sciences properties from labs to manufacturing spaces, controlled environments and more.

Find Your Perfect Space

Browse our life sciences listings in San Diego

Related Insights

  • Local Response | Intelligent Investment

    San Diego Market

    April 11, 2025

    San Diego is one of the top three U.S. life sciences clusters. More than 89,000 people work in the local industry, over 17,000 of whom are in life sciences research and development (R&D) roles.

  • Book | Evolving Workforces

    U.S. Life Sciences Research Talent 2023

    June 5, 2023

    Amid unprecedented growth for the life sciences sector, this report identifies the top 25 markets for life sciences research talent.

  • Book | Adaptive Spaces

    2023 U.S. Life Sciences Outlook

    April 3, 2023

    The U.S. life sciences industry has returned to a more normal pace at the start of 2023.

  • Chapter | Intelligent Investment

    Life Sciences

    December 13, 2022

    In 2023, Pandemic-fueled demand and capital infusion will give way to more normal market conditions, with better opportunities for occupiers.

CBRE Life Sciences

CBRE provides the full spectrum of services across all core and growth life sciences markets.

lab technician at work